-
Arrakis, Roche Ink Multi-Billion Dollar Deal to Develop RNA-based Therapies
contractpharma
April 10, 2020
Arrakis Therapeutics, a biopharmaceutical company engaged in the discovery of a new class of small molecule medicines that directly target RNA.
-
US regulator postpones decision on Roche’s SMA drug risdiplam
pharmaceutical-technology
April 09, 2020
The US Food and Drug Administration (FDA) has postponed the decision on Roche’s new drug application (NDA) of risdiplam to treat spinal muscular atrophy (SMA).
-
Roche Accelerates Phase III Actemra Trial in COVID-19
contractpharma
April 09, 2020
Receives $25 million in support from BARDA to evaluate safety and efficacy in severe COVID-19 pneumonia.
-
Roche’s Atezolizumab receives DCGI approval for treatment of metastatic triple-negative breast cancer in India
expresspharma
April 09, 2020
Atezolizumbab is the first immunotherapy drug to be approved globally for treatment of unresectable locally advanced and metastatic triple-negative breast cancer。
-
Roche response to COVID-19 pandemic
worldpharmanews
March 27, 2020
Roche Group, provided an update on the various actions the company is taking to address the COVID-19 pandemic.
-
Forge, Roche Enter Antibiotic Alliance
contractpharma
March 26, 2020
To develop novel antibiotic to treat serious lung infections attributed to antibiotic-resistant Gram-negative bacteria.
-
Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia
worldpharmanews
March 23, 2020
Roche is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration ...
-
Roche to start Phase III trial of Actemra in Covid-19 patients
pharmaceutical-technology
March 20, 2020
Roche has collaborated with the US Food and Drug Administration (FDA) to conduct a Phase III clinical trial of Actemra/RoActemra (tocilizumab) in hospitalised adults with severe Covid-19 pneumonia.
-
Roche Ships First 400,000 COVID-19 Tests
contractpharma
March 18, 2020
Labs across U.S. to begin patient testing under FDA Emergency Use Authorization.
-
Roche's cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization
worldpharmanews
March 17, 2020
Roche announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the cobas® SARS-CoV-2 Test.